Delivery Order SPE2DB20D3103-SPE2DB21FQ1A3
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office division. The $31,672.20 fixed-price contract is for the supply of 420 mg vials of the oncology medication Kanjinti. The contract has an ultimate completion date of August 22, 2024. AmerisourceBergen, a large pharmaceutical distributor, has been awarded multiple indefinite delivery contracts (IDCs) with the DLA and other federal agencies to provide a wide...
- The Defense Logistics Agency (DLA) awarded a Delivery Order valued at $11,981.16 to AmerisourceBergen Drug Corp for the supply of Kanjinti 420 mg vials. This is a firm fixed-price, competitively awarded contract with no set-aside designation, with an ultimate completion date of November 14, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its corporate office location. Kanjinti is a biosimilar medication...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order issued by the Defense Logistics Agency (DLA) with a ceiling value of $2,029.97. The contract is for the provision of pharmaceutical products and medical supplies to support military healthcare programs. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999, which serves as the primary vehicle for the...
- This federal contract award to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) is for the delivery of pharmaceutical products and medical supplies to the U.S. government. The contract, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, has a ceiling value of $80,626.10. It is a Firm Fixed Price Delivery Order contract with an ultimate completion date of December 4, 2020. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order (SPE2DB21FP16K) valued at $5,664.83 for pharmaceutical and medical products. The order was placed by the Defense Logistics Agency (DLA), a defense agency, and has no set-aside requirements. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of KENALOG-40 200 MG/5 ML VIAL 5ML, a pharmaceutical product, to support federal healthcare requirements. The $4,594.32 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, on September 8, 2021, with a completion date of September 9, 2021. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order with a ceiling value of $6,414.11. The contract is for pharmaceutical and medical supplies to support the Defense Logistics Agency (DLA) Troop Support Medical. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026, which serves as the primary vehicle for the company to deliver...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order (SPE2DB20D2104|SPE2DB24FT00S) valued at $1,182.71 for pharmaceutical products. The contract was awarded by the Defense Logistics Agency (DLA) and has an ultimate completion date of April 2, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as the primary vehicle for...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of pharmaceutical products and medical supplies. The contract has a ceiling value of $3,376.86 and an ultimate completion date of September 8, 2022. The contract is a firm fixed-price type and does not have a set-aside designation, indicating open competition. The delivery order is part of a larger Indefinite Delivery Contract (IDC) between Cencora,...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $18,508.86. The contract, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, is for the provision of various pharmaceutical products and medical supplies to support military healthcare programs. The award is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB21FQ1A3Delivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of the pharmaceutical product KANJINTI 420 MG VIALS. The contract has a ceiling value of $56,057.30 and runs through September 1, 2021. The contract was awarded on August 31, 2021 and is a firm-fixed-price contract. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries. The contract award did not include any set-aside designations, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $56.1k | 8/31/21 |